Filing Details
- Accession Number:
- 0001358403-15-000059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-05 17:07:53
- Reporting Period:
- 2015-08-03
- Filing Date:
- 2015-08-05
- Accepted Time:
- 2015-08-05 17:07:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358403 | Bellicum Pharmaceuticals Inc | BLCM | Pharmaceutical Preparations (2834) | 201450200 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1626859 | J. Thomas Farrell | C/O Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-08-03 | 2,500 | $20.24 | 68,862 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on March 26, 2015.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.90 to $20.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The total amount of shares shown in Column 5 on Table I includes one share omitted from the prior reports due to the rounding error.
- Includes 644 shares acquired by Reporting Person under the Issuer's Employee Stock Purchase Plan on June 10, 2015.
Billionaire Hedge Funds
